News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. What Vistra's latest earnings event means for stock watchers Vistra Corp (VST) put fresh numbers on the table with its second quarter 2026 earnings, …
Sharemaestro market context Price below Trend Line 52 weeks -29.3% · Next-week setup negative 44.2%This article provides current stock information for Visteon Corp (VC), including its latest stock price, market capitalization, and P/E ratio. It notes that this page will feature news, earnings, analyst ratings, and key developments related to Visteon Corp, with more updates expected soon. The …
This article first appeared on GuruFocus. Adjusted EBITDA (Q2 2026): $1,767 million, a more than 30% increase compared to $1.35 billion in Q2 2025. Generation Segment Adjusted EBITDA: Approximately $994 million in Q2 2026, up from approximately $593 million in Q2 2025. Retail Segment …
Sharemaestro market context Price below Trend Line 52 weeks -29.3% · Next-week setup negative 44.2%The article discusses Vistra (VST) as a well-positioned competitive generator in the USA, poised to benefit from increasing energy demand, especially from data centers and AI. Key advantages include its scale, nuclear assets, integrated retail model, and a more attractive valuation compared to peers …
Earnings Call Insights: Vistra Corp. (VST) Q2 2026 MANAGEMENT VIEW * “We remain on track to achieve another record result in 2026 as the business continues to perform very well,” said (President, CEO & Director James Burke), citing “a structurally improved demand environment” with …
Sharemaestro market context Price below Trend Line 52 weeks -29.3% · Next-week setup negative 44.2%Vistra Corp. reported a significant 30% increase in Q2 2026 Adjusted EBITDA to $1.77 billion, driven by a 68% surge in generation earnings. The company reaffirmed its full-year guidance and launched Helix Digital Infrastructure, a rack-to-grid platform partnership with KKR, NVIDIA, and the Kuwait …
Investors interested in stocks from the Medical - Products sector have probably already heard of Envista (NVST) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look. …
State Street Corporation has reported a beneficial ownership of 5% in Vistra Corp (NYSE: VST), totaling 16,867,244 common shares. This disclosure, made via a Schedule 13G filing, indicates shared voting power over 11,948,766 shares and shared dispositive power over 16,850,452 shares. The stake is …
Vistra Corp reported Q2 2026 adjusted earnings of $1.68 per share and revenue of $4.02 billion, missing analyst estimates. Despite the miss, adjusted EBITDA rose 30.8% year-over-year, driven by strong generation and retail performance, leading the company to reaffirm its full-year guidance for 2026. …
Vistra (NYSE:VST) shares declined by 1.8% despite a 31% increase in adjusted EBITDA to $1.767 billion for the quarter, as market attention focused on steady full-year guidance and reduced GAAP profit. The company maintained its 2026 adjusted EBITDA guidance of $6.8-$7.6 billion, requiring a …
Dimensional Fund Advisors LP increased its holdings in Civista Bancshares, Inc. by 4.4% in the first quarter, bringing its total to 950,330 shares valued at approximately $21.7 million. Institutional investors now own 52.1% of the company's stock. Civista Bancshares reported quarterly EPS of $0.69, …
Vistra Corp. (NYSE: VST) reported second-quarter 2026 results showing a revenue miss at $4.02 billion, below analyst estimates, causing shares to slip by 1.2% in pre-market trading. Despite this, the company achieved strong adjusted EBITDA growth of 31% to $1.77 billion and reaffirmed its …
Vistra Corp. (NYSE:VST) reported second-quarter 2026 revenue of $4.02 billion, missing the analyst consensus of $5.73 billion, causing its stock to edge down 1.22% in pre-market trading. Despite the revenue miss, the company saw a 31% increase in Ongoing Operations Adjusted EBITDA to $1.77 …
Vistra Corp. (VST) reported its second-quarter revenue of $4.02 billion, falling short of the FactSet estimate of $5.46 billion. The company's Q2 net income and operating revenue both experienced a decline. Vistra Corp. is an integrated retail electricity and power generation company operating a …
Vistra's Q2 2026 results show a significant increase in Ongoing Operations Adjusted EBITDA by 31% to $1.767 billion, driven by higher realized prices and contributions from Lotus assets. However, GAAP net income declined 6.7% due to substantial unrealized mark-to-market hedging losses. The company reaffirmed …
Palouse Capital Management Inc. has taken a new $3.15 million position in Vistra Corp. (NYSE:VST) by purchasing 19,849 shares. Vistra recently reported strong quarterly earnings, beating analyst estimates for both EPS and revenue, and institutional investors collectively own 90.88% of the company. Analysts maintain …
Barclays analysts have offered varied ratings for several healthcare companies. Etzer Darout maintained a Buy rating for Protagonist Therapeutics (PTGX) with a $153.00 price target, while Luke Sergott gave Qiagen (QGEN) a Hold rating with a $38.00 target. Glen Santangelo maintained a Buy rating …
Avista Corp (AV6) reported its Q4 2025 earnings, missing consensus EPS expectations with an actual EPS of €0.75 against a consensus of €0.88. However, the company beat revenue estimates, reporting €462.29M compared to an expected €447.46M, marking a 0.04% YoY revenue growth. The earnings …
This article first appeared on GuruFocus. Revenue: Fourth-quarter revenue increased 9.7% to $501.4 million; full-year revenue was $1.954 billion, up 9.3%. Adjusted EBITDA: Fourth-quarter adjusted EBITDA was $126.9 million, up 15.2%; full-year adjusted EBITDA was $521.7 million, up 13.5%. Adjusted EBITDA Margin: Fourth-quarter margin …
Vistagen Therapeutics, Inc. announced topline results from an exploratory Phase 2 study of intranasal fasedienol for social anxiety disorder. The study met its safety objective and showed efficacy signals, particularly in patients with very severe social anxiety, which will inform discussions with the FDA …
Civista Bancshares, Inc. reported strong second-quarter 2026 results with revenue of $65.55 million and net income of $14.32 million, showing significant year-over-year growth. This improvement was driven by the successful integration of its FSB acquisition and higher noninterest income. Diluted earnings per share for …
Renaissance Technologies LLC decreased its stake in Avista Corporation (NYSE:AVA) by 31.8% in the first quarter, selling 68,900 shares and retaining 147,815 shares valued at approximately $5.9 million. Despite this, institutional investors collectively own 85.24% of Avista. The company reported strong Q1 earnings per …
Covista's (NYSE:CVSA) Q2 CY2026 Sales Top Estimates Vocational education company Covista (NYSE:CVSA) beat Wall Street's revenue expectations in Q2 CY2026, with sales up 9.7% year on year to $501.4 million. The company expects the full year's revenue to be around $2.07 billion, close to …
VistaGen Therapeutics has received a 180-day extension from Nasdaq, lasting until February 1, 2027, to meet the $1.00 minimum bid price requirement for its common stock. Failure to comply within this period could lead to delisting. Analysts currently rate VTGN as a Hold with …
Total Q4 enrollment up 8.4% and revenue up 9.7% YoY Chamberlain accelerates total enrollment growth to 1.6% Revenue up 9.3% YoY for fiscal year 2026 Fiscal year 2026 diluted earnings per share $7.04; Adjusted EPS $8.25, growth of 23.7% YoY Fourth quarter highlights GAAP …
Envista Holdings Corporation (NYSE: NVST) reported strong second-quarter 2026 results, achieving 5.0% core sales growth and a 58% year-over-year increase in adjusted diluted EPS. The company raised its full-year 2026 guidance for core sales growth, adjusted EBITDA growth, and adjusted EPS, reflecting confidence in …
Envista Holdings (NVST) exceeded Wall Street expectations for Q2 2026, reporting adjusted earnings of $0.41 per share on revenue of $730.5 million, surpassing analyst estimates. The company raised its full-year 2026 guidance, citing strong performance across its dental portfolio, increased margins, and robust free …
Search by ticker symbol or company name and select a result to open its chart.